Page 375 - Syndipharma

Type Indication Product Strength Dosage Form Status

20 mg/ml Prefilled Syrings
Glatiramer
IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY
Acetate
40 mg/ml Prefilled Syrings
Immune System
Anti-Ms Drugs Teriflunomide 14 mg F. C. Tablet
Modifiers
Fingolimod 0.5 mg Capsule

Fampridine 10 mg F. C. Tablet

Antidiabetic
Antidiabetics Pioglitazone 15, 30 & 45 mg Tablets
Agent
Availble
50 & 100 mg Capsules
Systemic Anti- Fluconazole
fungal
150 mg Capsules
Antibacterials
Antifungals Clindamycin 300 mg/2 ml Ampoules
Systemic Antibac-
terial 20& 80 mg/2ml &
Gentamicin Ampoules
40mg/ml
Dexametha-
Corticosteroids 8 mg / 2 ml Ampoules
sone

Naproxen
NSAID 220 mg Softgel Capsules
Analgesics Sodium
Anti-inflamma-
tory Drugs Centrally actung
Antipyretics analgesic & anti- Acetamino- 1000 mg Softgel Capsules
phen Codeine
pyretic

Histamine Antag- Antihistamine
onist Decongestant Softgel Capsules
Antihistamines
Bronchodilators Pseudoephed-
Anti-asthma Decongestant 30 mg Softgel Capsules
Drugs rine
Expectorants Guaifenesin 100&200 mg Softgel Capsules

Antihyperlipid- coming soon
emia Drugs Statin Rosuvastatin 20 mg F.C.Tablets

Nitroglycerin
Antianginal, Vaso-
dilator Extended 2.6 & 6.4 mg Tablets
Release
Cardiovascular
Drugs Lonotrolytes Milrinone 10 mg Ampoules

Phosphate Effervescent
Electrolytes
Sodium Tablets

5 Amino salicylic Sulfasalazine 500 mg Tablets
Gastrointestinal Acid Derivative
Drugs
H₂ Antagonist Ranitidine 150 & 300 mg Capsules

374